Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04810234
Other study ID # 65751.068.2018
Secondary ID METC183019
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2020
Est. completion date June 1, 2021

Study information

Verified date March 2021
Source Maastricht University Medical Center
Contact Abraham Beckers, MD
Phone +31433881844
Email ab.beckers@maastrichtuniversity.nl
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Transcutaneous vagal nerve stimulation (tVNS) has been applied to a number of disease areas including visceral pain, depression, cluster headache and Alzheimer's disease. However, there is marked heterogeneity in these studies pertaining to i) the anatomical site of stimulation (neck, inner concha or tragus of ear), and ii) the waveform parameters of the stimulating impulse. This exploratory cross-sectional study will address these knowledge gaps by comparative functional neuroimaging of the neural correlates of tVNS with disparate anatomical sites and electrical waveform characteristics during rest in healthy participants.


Recruitment information / eligibility

Status Recruiting
Enrollment 16
Est. completion date June 1, 2021
Est. primary completion date June 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion criteria: - Of female sex; - Healthy participants (defined as those without a pre-existing medical comorbidity) - Age between 18 and 40 years; - BMI between 18 and 30 kg/m2; - Women on oral contraceptives only - All subjects should be right-handed. - Inclusion will be determined on the basis of availability. Subjects should be able to attend for 2 scanning sessions. Exclusion criteria - Presence of metallic prostheses, pacemakers, metal clips on blood vessels, metal parts in the eye, an intrauterine device, metal braces, tattoos and/or other metal objects; - History of major head trauma or head/brain surgery; - History of claustrophobia; - History of severe or chronic cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic, haematological/immunologic, HEENT (head, ears, eyes, nose, throat), dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological/psychiatric diseases, major surgery and/or laboratory assessments which might limit participation in or completion of the study protocol; - Use of regular medication, including vitamin and iron supplementation, except oral contraceptives, within 14 days prior to start of the study; - Pregnancy, lactation, wish to become pregnant; - High alcohol consumption (>15 alcoholic units consumed per week); - Using drugs of abuse; - Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study; - Participants unable to provide informed consent - Participants with any systemic disease or medications that may influence the autonomic nervous system (e.g. beta-agonists or Parkinson's disease) - Current smokers or current use of nicotine in any other way (including E-cigarettes and patches) - History of clinical anxiety or depression, or a hospital anxiety or depression score >8 - Participants whom score 8 or more on the HADS-questionnaire at study commencement - Patient whom have cardiovascular conduction problems - Patient with cochlear implants - Not meeting any of the inclusion criteria above - Any evidence of structural brain abnormalities examined by anatomical MRI will lead to exclusion

Study Design


Related Conditions & MeSH terms

  • fMRI
  • Nucleus of the Solitary Tract (NTS)
  • Transcutaneous Vagal Nerve Stimulation (tVNS)

Intervention

Device:
transcutaneous vagal nerve stimulation (tVNS)
Cervical and auricular transcutaneous stimulation of the vagus nerve

Locations

Country Name City State
Netherlands Maastricht University Medical Center Maastricht
United Kingdom Queen Mary University of London. Wingate Institute of Neurogastroenterology London

Sponsors (2)

Lead Sponsor Collaborator
Maastricht University Medical Center Wingate Institute of Neurogastroenterology

Countries where clinical trial is conducted

Netherlands,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood oxygenation level dependent (BOLD) signal activity in the CAN during tVNS fMRI related outcome measure During stimulation (difference between stim on - stim off blocks)
Secondary Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during auricular tVNS (parameter set 1) fMRI related outcome measure During stimulation (difference between stim on - stim off blocks)
Secondary Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during cervical tVNS )(parameter set 1) fMRI related outcome measure During stimulation (difference between stim on - stim off blocks)
Secondary Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during auricular tVNS (parameter set 2) fMRI related outcome measure During stimulation (difference between stim on - stim off blocks)
Secondary Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during cervical tVNS (parameter set 2) fMRI related outcome measure During stimulation (difference between stim on - stim off blocks)
Secondary Voxel-wise dependent BOLD signal activity in the NTS of the brainstem; somatosensory cortex; insular cortex; ACC, hypothalamus; thalamus and amygdala during subliminal auricular tVNS (parameter set 1) fMRI related outcome measure During stimulation (difference between stim on - stim off blocks)
Secondary Functional connectivity / Network Connectivity of CAN regions during "active tVNS" block [to all 5 points as identified above] fMRI related outcome measure During stimulation (difference between stim on - stim off blocks)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03338634 - Pilot Testing of Food Images in Children
Recruiting NCT05645835 - Dynamic Neural Systems Underlying Social-emotional Functions in Older Adults N/A
Recruiting NCT01434368 - A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty
Recruiting NCT06221722 - Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
Completed NCT01037608 - Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation Phase 1
Recruiting NCT06403852 - Investigating Near-Threshold Perception During Anesthetic Sedation Phase 2
Completed NCT04065061 - Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations N/A
Completed NCT00001284 - Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
Recruiting NCT01617408 - Brain Stimulation and Vision Testing
Terminated NCT02089776 - fMRI Neurofeedback for Motor Rehabilitation
Completed NCT02119624 - Neural Substrates of Approach-Avoidance Conflict
Recruiting NCT01087281 - Top-Down Attentional Control of Visual-Processing
Recruiting NCT04075890 - Arbitration Between Habitual and Goal-directed Behavior in Obsessive-compulsive Disorder: Circuit Dynamics and Effects of Noninvasive Neurostimulation N/A
Recruiting NCT00004577 - Study of New Magnetic Resonance Imaging Methods of the Brain
Completed NCT03341247 - Brain Mechanisms of Overeating in Children
Completed NCT04726176 - COVID-19 and the Brain
Recruiting NCT05441865 - Cardiovascular Risk Factors and Cognitive Trajectories
Terminated NCT01260740 - The Effect of Transcranial Magnetic Stimulation on Learning With Reward in Healthy Humans N/A
Completed NCT01779024 - Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers Phase 2
Completed NCT01175993 - Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adults With Traumatic Brain Injury Phase 1/Phase 2